Back to Search Start Over

VANTAGE 095: final results from a global, single-arm, phase 2b trial of vorinostat in combination with bortezomib in salvage multiple myeloma patients

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..6246f3bbf57edc6f5a5e90ec36ac5670